| Literature DB >> 33050462 |
Bingyan Yang1, Yixin Dong1, Fei Wang1, Yu Zhang1.
Abstract
Polyphenols are micronutrients that are widely present in human daily diets. Numerous studies have demonstrated their potential as antioxidants and anti-inflammatory agents, and for cancer prevention, heart protection and the treatment of neurodegenerative diseases. However, due to their vulnerability to environmental conditions and low bioavailability, their application in the food and medical fields is greatly limited. Nanoformulations, as excellent drug delivery systems, can overcome these limitations and maximize the pharmacological effects of polyphenols. In this review, we summarize the biological activities of polyphenols, together with systems for their delivery, including phospholipid complexes, lipid-based nanoparticles, protein-based nanoparticles, niosomes, polymers, micelles, emulsions and metal nanoparticles. The application of polyphenol nanoparticles in food and medicine is also discussed. Although loading into nanoparticles solves the main limitation to application of polyphenolic compounds, there are some concerns about their toxicological safety after entry into the human body. It is therefore necessary to conduct toxicity studies and residue analysis on the carrier.Entities:
Keywords: bioavailability; loading; nanoformulations; polyphenols
Mesh:
Substances:
Year: 2020 PMID: 33050462 PMCID: PMC7587200 DOI: 10.3390/molecules25204613
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic representation of nanoformulations to enhance the bioavailability and physiological functions of polyphenols.
Antioxidant activities of some extracts/compounds from plants.
| Polyphenols | Antioxidant Activity | Detection Method * | References |
|---|---|---|---|
| Extracts of Hippophae species | Regulate enzyme activity, affect the antioxidant reaction of cells | DPPH assay | [ |
| Extracts of sweet potato leaves | Decrease the level of intracellular ROS | Photochemiluminescence assay, ORAC assay | [ |
| Polyphenols from stevia rebaudiana | Radical scavenging, regulate enzyme activity | DPPH assay, ABTS assay | [ |
| Curcumin | Direct reaction with free radicals, regulation of antioxidant-related enzyme activity and gene expression | DPPH assay, ABTS assay, total phenolic content assays | [ |
| Extracts of Nymphaea nouchali leaf | Reducing DNA damage and attenuating oxidative stress-induced cell death | FRAP assay, ORAC assay, DPPH assay | [ |
| Persimmon vinegar polyphenols | Activate of the Nrf2 antioxidative pathway | Fluorescent probe method, DPPH assay, total phenolic content assays | [ |
| Anthocyanins | Radical scavenging, reduce the catalytic effect of metal ions | DPPH assay, T-AOC assay, ABTS assay, FRAP assay | [ |
| Grape seed extract | Decrease the oxidized LDL in plasma, regulate enzyme activity | Antioxidant enzyme activity, DPPH assay, ORAC assay, ABTS assay | [ |
| (−)-Epicatechin and procyanidin | Preservatives for fruit, radical scavenging | DPPH assay, hydroxyl radical scavenging capacity method, superoxide anion radical method | [ |
| Extracts of blueberries | Regulate enzyme activity, chelate trace metals, regulate miRNA | FRAP assay, DPPH assay, ABTS assay | [ |
| Extracts of pine | Radical scavenging, the skin against oxygen reactive species | DPPH assay, superoxide anion radical method, hydroxyl radical scavenging capacity method | [ |
| Extracts of tea | Increase antioxidant enzyme activity, inhibit lipid peroxidation, radical scavenging | DPPH assay, FRAP assay, TEAC assay | [ |
* DPPH, 2,2-diphenyl-1-picrylhydrazyl; ORAC, oxygen radical absorbance capacity; ABTS, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid; FRAP, fluorescence recovery after photobleaching; T-AOC, total antioxidant capacity; TEAC, trolox equivalent antioxidant capacity.
Anti-cancer effects of some polyphenols.
| Polyphenol | Cancer Type/ | Major Outcomes | References |
|---|---|---|---|
| Curcumin | MBA-MB-231cells, MCF-7 cells | Down-regulate the mRNA expression of Vimentin, Fibronectin, and β-catenin; up-regulate E-cadherin mRNA expression levels | [ |
| HCT-116 cells | Reduce the expression of SIRT1 protein, suppress the oncogenicity of human-colon cancer cells | [ | |
| T98G, U87MG, T67 cells, HCT-116 cells | Inhibit AP-1 and NF-κB signaling pathways, suppress JNK activation induced by carcinogens | [ | |
| Resveratrol | LNCaP cells | Induce the expression of COX-2, promoting ERK1/2 activation, and facilitate p53-dependent anti-proliferation gene expression | [ |
| NSCLC cells | Prevent tumorigenesis and progression, and down-regulate EGFR/Akt/ERK1/2 signaling pathway | [ | |
| Apc10.1 cells | Show superior efficacy than high doses due to the pro-oxidant activity and AMPK signaling upregulation | [ | |
| Hela cells | Inhibit the expression of PLSCR1, leading to the growth inhibition of HeLa cells | [ | |
| SGC7901, BGC823 cells | Inhibit the invasion and migration of human gastric cancer cells | [ | |
| Quercetin | MDA-MB-231 cells | Increase FasL mRNA expression and p51, p21, and GADD45 signaling activities, induce protein level, transcriptional activity, and nuclear translocation of Foxo3a | [ |
| AsPC-1, CRL-4023, PANC-1 cells | Reduce the expression levels of cellular FLICE-like inhibitory protein, activate c-Jun N-terminal kinase (JNK) | [ | |
| A549 cells | Trigger BCL2/BAX-mediated apoptosis, as well as necrosis and mitotic catastrophe | [ | |
| PC-3 cells | Decrease tumor improvement, down-regulate Ki67, and enhance caspase 7 | [ | |
| EGCG | Breast T47D | Up-regulate PTEN, CASP3, CASP9, down-regulate AKT | [ |
| Genistein | Pancreatic Mia-PaCa2 | Induce mitochondrial apoptosis, block cell cycle and regulate STAT3 | [ |
| Colorectal HCT 116 | Inhibite cell proliferation, induce apoptosis of colorectal cancer cells | [ | |
| Daidzein | Colorectal HT-29, MIA PaCa-2 | Cytotoxic effects on both MIA PaCa-2 and HT-29 cell lines | [ |
| Ovarian SKOV3 | Up-regulate B-cell lymphoma 2-associated X protein, cytochrome c, down-regulate pCdc25c, Cdc25c | [ | |
| BEL-7402 | Increased the levels of reactive oxygen species (ROS) and induce a decrease in mitochondrial membrane potential | [ | |
| Chrysin | HCT-116; | The combination of chrysin and cisplatin promoted apoptosis of HepG2 cells in both dose- and time- dependent manners | [ |
| A549 | Reinforce the therapeutic efficacy of DTX and mitigate | [ |
Figure 2Main structure of the phosphatidylcholine, representative phosphatidylcholine groups and main fatty acid residues.
Polyphenols complexed with phospholipids.
| Phytosomal | Biological Activity | Route of Administration | Reference |
|---|---|---|---|
| Moringa oleifera leaf phytophospholipid complex | Wound healing | In vitro | [ |
| Quercetin phytosome | Antimicrobial, anti-infammatory, anticancer | Oral | [ |
| Curcumin phytosome | Antioxidant | In vitro, oral | [ |
| Rutin-phospholipid | Anticytotoxicity, neuroprotection | In vitro | [ |
| Catechin phyto-phospholipid | Antioxidant | In vitro | [ |
| Luteolin phytosome | Hepatoprotective | Oral | [ |
| Silybin phospholipid | Hepatoprotective, antioxidant, anticancer | In vivo | [ |
| EGCG phytosome | Anticancer | Oral | [ |
| Grape seed phytosome | Anticancer | Oral | [ |
| Quercetin phytosome | Antioxidant, anti-inflammatory | Oral | [ |
| Silybin phytosome | Hepatoprotective | Oral | [ |
| Persimmon phytosome | Antioxidant | Oral | [ |
Figure 3Liposome structure and drug loading diagram: (A) Cross-section structure of liposome, made of phospholipid and cholesterol, showing the magnified molecular structure of a phospholipid that consists of a polar head and a non-polar tail. Phospholipid head is hydrophobic and comprises choline, phosphate and glycerol, while the tail is a hydrocarbon chain that shows lipophilicity. (B) A schematic representation of the structure and preparation of phytosomal curcumin. Reprinted from reference [134,159]. Copyright 2016 Elsevier Masson SAS, 2019 Elsevier Ltd.
Figure 4Schematic representation of niosome prepared by sorbitan monostearate (Span-60). Redrawn from reference [176]. Copyright 2014 Elsevier B.V.
Figure 5(A) The chemical structure of the gelatin. (B) Scanning electron microscopy (SEM) images of pure chitosan scaffold and (C) chitosan–gelatin scaffold. Redrawn from reference [195]. Copyright 2009 Elsevier Ltd.
Figure 6Schematic representation of the designed targeted EGCG NPs. Chemical structure of (-)- epigallocatechin-3-gallate (EGCG), the PEGylated PLGA polymers (PLGA-PEG), and the targeting ligands DCL and AG. Adapted from reference [213].
Figure 7Schematic representation of the size-controlled synthesis of γ-CD-MOFs through facile and green seed-mediated method. Adapted from reference [244]. Copyright 2018 American Chemical Society.
Figure 8(A) Scheme of thiolated chitosan/poly(ethylene glycol) diacrylate (TCS/PEGDA) injectable hydrogel for localized intratumoral delivery of anti-cancer drugs. (B) Curcumin release behavior from TCS/PEGDA injectable hydrogel in PBS buffer at 37 °C with shaking (100 rpm). TP0 is the gel with micro porous starch but without lysozyme; TP1, TP2 and TP3 are the gels with micro porous starch adsorbed 0.46, 0.60 and 0.75 g/g lysozyme, respectively. (C) HepG2 cells viability determined using MTT assay when incubated with free curcumin, and curcumin loaded TCS/PEGDA injectable hydrogels with (TP3) or without (TP0) lysozyme, respectively. Adapted from reference [252]. Copyright 2017 Elsevier B.V.
Figure 9Synthesis of cholesterol-conjugated PAMAM (PAM-Chol) (A) and preparation of the pHO-1/PAM-Chol/Res complex (B). The heme oxygenase-1 gene (pHO-1). Adapted from reference [269]. Copyright 2018 Royal Society of Chemistry.
Figure 10Morphology characterization of CUR-AuNCs: (A) TEM of CUR-AuNCs; the inset image is SAED pattern. (B) HR-TEM; arrow indicates the collections of atoms to form a cluster. (C) Bio-AFM height image of CUR-AuNCs. Adapted from reference [284]. Copyright 2018 American Chemical Society.